Immunohistochemistry (IHC) market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Immunohistochemistry (IHC) Market Forecast 2024-2028

The Immunohistochemistry (IHC) market size is estimated to grow by USD 1.33 billion, at a CAGR of 8.36% between 2023 and 2028. The growth of the market is fueled by the increasing global healthcare expenditure, as nations allocate resources to enhance healthcare infrastructure, diagnostics, and research. Rising healthcare costs empower providers and research institutions to invest in state-of-the-art equipment, such as automated immunohistochemistry systems, high-quality antibodies, and detection reagents. As healthcare spending continues to rise, these companies invest in research and development, accelerating the adoption of advanced techniques globally. Increased healthcare spending not only facilitates the acquisition of sophisticated tools but also supports training programs for professionals, fostering the effective use of immunohistochemistry in disease diagnosis, biomarker discovery, and therapeutic development. This positive feedback loop helps the growth of the market, enabling healthcare providers and research institutions to leverage advanced technologies for enhanced patient care and scientific advancements.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation by Application, End-user and Geography Analysis

The market is evolving with advancements in biomarkers and cell population analysis, driven by innovative companies like Mindpeak. Specific applications in lung tissue and breast tissue analysis are enhancing diagnostic accuracy through mass spectrometric detection and Fc-fusion technologies. Antibody fragments and antibody-drug conjugates are key players in targeted pathology solutions, bolstered by Digital imaging of stained tissue slides and electronic images. Pathologists benefit from technologies such as slide scanners and RNA sequencing for comprehensive transcriptome sequencing and gene expression analysis. The integration of Next Generation Sequencing (NGS) and DNA sequencing techniques offers technologically sophisticated immunohistochemistry remedies, expanding IHC diagnostic solutions across various fields. This includes applications in immunotherapies and research on neurodegenerative disorders, including the potential use of cannabidiol in treatment.

Application Analysis 

The market share growth by the diagnostic application segment will be significant during the forecast period. Immunohistochemistry is a widely used technique in the field of diagnostics, particularly in pathology and molecular biology. It involves the localization and visualization of specific proteins or antigens in tissue sections using antibodies that bind to those antigens. The technique plays a crucial role in understanding disease processes, identifying biomarkers, and aiding in patient diagnosis and treatment.

Get a glance at the market contribution of various segments Download PDF Sample

The ??????diagnostic application was the largest and was valued at USD 1.30 billion in 2018. As researchers and clinicians discover new biomarkers associated with diseases, the need for techniques such as immunohistochemistry to detect and visualize these markers in tissue samples increases. These biomarkers can be used for early detection, prognosis, and predicting treatment response. The growing demand for immunohistochemistry in diagnostics is attributed to its role in advancing personalized medicine, improving disease understanding, and aiding in the development of targeted therapies. As technology continues to evolve and our understanding of disease mechanisms deepens, the significance of diagnostics is likely to increase further, which will have a positive impact on the growth of the market during the forecast period.

End-user Analysis 

The robust demand for immunohistochemistry tests in hospitals and diagnostic laboratories is driven by various factors related to patient care, disease diagnosis, and treatment planning. It plays a pivotal role in the diagnosis and staging of various types of cancers, such as bladder cancer, breast cancer, and colorectal cancer. It helps pathologists identify specific protein markers that indicate the origin and characteristics of tumors. Hospitals often engage in clinical trials and research to advance medical knowledge and treatment options. It is a vital tool in these endeavors, allowing researchers to characterize tissue samples and validate findings. Advances in automation and digital imaging have made immunohistochemistry tests more efficient and reproducible, which will have a positive impact on the growth of the market during the forecast period.

Immunohistochemistry is widely used by academic and research institutes for a wide range of applications, helping to advance various scientific disciplines. In academic research, immunohistochemistry allows for the visualization and analysis of specific proteins within tissue samples, providing important insights into cellular processes, disease mechanisms, and potential therapeutic targets. Companies such as Thermo Fisher Scientific Inc. offer comprehensive immunohistochemistry solutions, including antibodies and detection systems, to help academic institutions conduct neuroscience research. In academic pathology departments, it is used for diagnostic purposes and helps to characterize diseases. Companies continue to play an important role by providing a diverse range of antibodies, detection systems, and related products to help researchers gain deeper insights into biological processes and diseases. These factors will drive the growth academic and research institute segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the immunohistochemistry (IHC) market during the forecast period.  The high demand for such tests in North America can be attributed to several factors that reflect the advanced healthcare system, research capabilities, and commitment to precision medicine in the region. North America, particularly the US and Canada, boasts a well-developed healthcare infrastructure with numerous hospitals, research institutes, and clinics. These facilities have the resources and technology to perform sophisticated diagnostic tests such as immunohistochemistry. The region is a hub for medical research and innovation. World-renowned universities, research centers, and pharmaceutical companies are often at the forefront of developing new diagnostic techniques and therapies. 

In addition, the high demand for tests in North America is a result of the region's focus on precision medicine, its robust healthcare and research infrastructure, and its leadership in medical innovation. As healthcare continues to advance and molecular-based treatments become more common, the demand for tests is likely to remain high in North America, which will positively impact the growth of the market during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 15 market companies, including:

Agilent Technologies Inc. - The company offers immunohistochemistry portfolio which is a complete solution with a high focus on quality and service that helps simplify work processes, removes variation, and minimizes possible staining imperfections.

• Bio Rad Laboratories Inc.
• Bio SB, Bio Techne Corp.
• Biocare Medical LLC
• BioGenex Laboratories Inc.
• CANDOR Bioscience GmbH
• Cell Signaling Technology Inc.
• Danaher Corp.
• Eagle Biosciences Inc.
• Elabscience Biotechnology Inc.
• F. Hoffmann La Roche Ltd.,
• Lunaphore Technologies SA
• Merck KGaA
• Miltenyi Biotec B.V. and Co. KG
• PerkinElmer Inc

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics 

The market is propelled by advancements in biomarkers and cell populations, with companies like Mindpeak leading innovation. Specific focus on lung tissue and breast tissue analysis using mass spectrometric detection and Fc-fusion technologies drives market growth. Challenges include navigating complex antibody patents and addressing technologically sophisticated immunohistochemistry remedies. Trends indicate an increasing demand for IHC diagnostic solutions in neurodegenerative disorders and immunotherapies, including the exploration of cannabidiol use. Understanding the impact of factors like cigarette smoking on diagnostics and drug testing presents ongoing challenges for diagnostics laboratories. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, market trends, and challenges. 

Key Market Drivers

The rising ageing population and increased prevalence of age-related diseases are notably driving market growth. As individuals age, they are more susceptible to chronic conditions, including various forms of cancer and neurodegenerative disorders. Immunohistochemistry, with its ability to analyze tissue samples for specific protein markers, becomes instrumental in the early detection, diagnosis, and characterization of these diseases. Cancer is more common in the elderly, so the aging population contributes to a higher incidence. It is important in cancer research and diagnostics because it identifies specific biomarkers and helps with personalized treatment strategies.

Moreover, the aging population is associated with an increased risk of neurodegenerative diseases such as Alzheimer's and Parkinson's. The growth of the immunohistochemistry market is closely related to the aging population's increased susceptibility to age-related diseases. The demand for precise and reliable diagnostic tools, such as those provided by prominent market companies, is expected to rise in tandem with the aging demographic, resulting in high growth for the market during the forecast period.

Significant Market Trends

The emergence of multiplexed immunohistochemistry is an emerging trend shaping market growth. This provides advanced capabilities for visualizing multiple biomarkers within a single tissue sample. This novel technique allows for a more complete understanding of the molecular and cellular composition of tissues, providing valuable insights for research and diagnostics. Multiplexed immunohistochemistry overcomes the limitations of traditional immunohistochemistry by allowing the detection of multiple proteins in the same tissue section, facilitating the study of complex biological interactions.

Also, this is especially important in cancer research, where characterizing tumour microenvironments and assessing various immune and stromal markers can greatly improve understanding. Multiplexed immunohistochemistry is expected to gain popularity due to its ability to provide detailed spatial and molecular information, facilitating the development of targeted therapies and precision medicine. These factors will propel the growth of the market during the forecast period.

Major Market Challenges

The lack of trained professionals in operating immunohistochemistry is a significant challenge hindering market growth. The specialized skill set required for successful immunohistochemistry execution includes histological techniques, pathology expertise, and molecular biology knowledge. The changing landscape of immunohistochemistry technologies, including the integration of automated platforms, necessitates ongoing training to keep professionals current on advancements, potentially creating a skills gap. Resource constraints, especially in resource-limited settings, may impede the allocation of funds and time for comprehensive training programs, limiting the number of skilled practitioners

Furthermore, the availability and accessibility of formal education and training programs focusing on immunohistochemistry techniques may be limited in some areas, exacerbating the shortage of skilled professionals. High turnover rates in laboratories and diagnostic facilities contribute to the ongoing need to train new personnel, causing disruptions in the consistency and quality of immunohistochemistry processes. These factors will impede the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2018. 

• Application Outlook
  • Diagnostic application
  • Research application
  • Forensic application

• End-user Outlook 
  • Hospitals and diagnostic laboratories
  • Academic and research institutes
  • Others

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of the Middle East & Africa

Market Analyst Overview 

The Immunohistochemistry (IHC) Market is propelled by a growing need for accurate patent analysis in diagnosing cancer diseases. Advanced IHC tests and digital pathology tools, integrated with IVD equipment from companies like Leica Biosystems and Danaher Corporation, are driving standardization and improving diagnostic accuracy. Healthcare professionals increasingly rely on digital immunohistochemistry for companion diagnostics in chronic diseases. The market sees a surge in monoclonal antibodies and antibody fragments for immunotherapy trials, highlighting their therapeutic significance. With a focus on Companion diagnostics and cancer incidence, Immunohistochemistry plays a pivotal role in companion diagnostic development and diagnostic testing in research organizations. The market's growth is also influenced by reimbursement policies and the impact of viral epidemics like Monkeypox on geriatric populations prone to Ischemic heart disease and stroke.

Moreover, the market is experiencing substantial growth driven by advancements in IVD equipment and innovations from companies like Akoya Biosciences in multiplex immunohistochemistry. This technology allows for the simultaneous detection of multiple biomarkers, enhancing diagnostic accuracy and efficiency. The market is influenced by elements such as IVD equipment, antibody drug, Immunofluorescence assay, and Antigen-antibody. The market is also witnessing increased demand for IHC kits and laboratory consumables as healthcare professionals focus on therapeutic significance and Immunology in combating various diseases, including infectious diseases and cardiovascular diseases prevalent among the geriatric population.

Furthermore, antibody drugs are gaining traction due to their targeted approach and therapeutic significance in treating complex conditions. Moreover, immunofluorescence assays are becoming integral for antigen-antibody interactions, aiding in precise diagnosis and treatment monitoring. With rising disposable income, there's greater accessibility to advanced IHC technologies, further driving market expansion. The intersection of Immunohistochemistry with geriatric healthcare and cardiovascular disease management underscores its crucial role in modern medicine.

Market Scope
Report Coverage	Details
Page number	168
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 8.36%
Market Growth 2024-2028	USD 1.33 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	7.63
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Germany, France, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Agilent Technologies Inc., Bio Rad Laboratories Inc., Bio SB, Bio Techne Corp., Biocare Medical LLC, BioGenex Laboratories Inc., CANDOR Bioscience GmbH, Cell Signaling Technology Inc., Danaher Corp., Eagle Biosciences Inc., Elabscience Biotechnology Inc., F. Hoffmann La Roche Ltd., Lunaphore Technologies SA, Merck KGaA, Miltenyi Biotec B.V. and Co. KG, PerkinElmer Inc, PHC Holdings Corp., SAKURA SEIKI Co. Ltd., Takara Holdings Inc., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market growth analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation and its contribution n of the market in focus to the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch